how long take bpc 157 Heal or Harm: Body Protective Compound-157 in the Gray Zone How BPC-157 Peptide Therapy Supports

Maquart, F., Bellon, G., Chaqour, B., Wegrowski, J., Patt, L., Trachy, R., Monboisse, J., Chastang, F., Birembaut, P., & Gillery, P

1 - 13 Thus, a hypothesis is that BPC 157 (since it is formed constitutively in the gastric mucosa, stable in human gastric juice, along with significance of NO-synthase and the basal formation of NO in stomach mucosa, greater than that seen in other tissues) exhibits a general, effective competition to both L-arginine analogues (i.e., L-NAME) and L-arginine

In other words, it is a research chemical and is not approved for human use

Jul 2014;17(4):145-55

Our licensed professionals provide these treatments with attention to comfort, safety, and optimal results